Avalyn Pharma
SEATTLE, WA · Founded 2011 · CIK 0001540171 · Biotech · Public
Inhaled therapeutic molecules for rare respiratory diseases
avalynpharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $242M
- 4 Form D · Oct 2023
- 36 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 30
- 12 granted · 18 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,090,000 | |
| Private capital raised | Form D · SEC | $16,621,473 | |
| Private capital raised | Form D · SEC | $35,499,998 | |
| Private capital raised | Form D · SEC | $189,182,622 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2785 | Nuvation Bio | — | $275M |
| 2786 | CELL REPROGRAMMING & THERAPEUTICS LLC | — | — |
| 2787 | Veradermics | — | $269M |
| 2788 | Avalyn Pharma | — | $242M |
| 2789 | Zylo Therapeutics Inc. | — | $4.9M |
| 2790 | Arbor Biotechnologies | — | $227M |
| 2791 | Metsera | — | $215M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Tiba AynechiDirector
- Lyn BaranowskiDirector · Executive Officer
- Daniel BurgessDirector
- Jill CarrollDirector
- Sofia IoannidouDirector
- Michael KamdarDirector · Executive Officer
- Jonathan LeffDirector
- Jonathan Leff, M.D.Director
- Cassandra LucaDirector
- Robert MittendorffDirector
- Peter MoldtDirector
- A. MontgomeryDirector · Executive Officer
- Bruce Montgomery, M.D.Director · Executive Officer
- Niall O'DonnellDirector
- Ketan PatelDirector
- Heather PrestonDirector
- Naveed SiddiqiDirector
- Mark Surber, Ph.D.Director · Executive Officer
- Richard VincentExecutive Officer
Patents
- Aerosol Pirfenidone And Pyridone Analog Compounds And Uses Thereofapplication
- Nintedanib And Nintedanib Combination Dry Powder Compositions And Usesapplication
- Nintedanib And Nintedanib Combination Dry Powder Compositions And Usesapplication
- Aerosol Pirfenidone And Pyridone Analog Compounds And Uses Thereofapplication
- Inhaled Imatinib For Treatment Of Pulmonary Arterial Hypertension (pah)application
- Aerosol Pirfenidone And Pyridone Analog Compounds And Uses Thereofgranted
- Specially Formulated Compositions Of Inhaled Nintedanib And Nintedanib Saltsapplication
- Specially Formulated Compositions Of Inhaled Nintedanib And Nintedanib Saltsgranted
- Aerosol Pirfenidone And Pyridone Analog Compounds And Uses Thereofgranted
- Inhaled Imatinib For Treatment Of Pulmonary Arterial Hypertension (pah)granted
- Nebulizer Device Optimization For Improved Aerosol Parameters And Uses Thereofapplication
- Nebulizer Device Optimization For Improved Aerosol Parameters And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.